Goldman Sachs
MED icon

Goldman Sachs’s Medifast MED Stock Holding History

Goldman Sachs’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,400
Closed -$559K – 5615
2020
Q3 		$559K Sell
3,400
-5,900
-63% -$971K ﹤0.01% 4427
2020
Q2 		$1.29M Buy
+9,300
New +$854K ﹤0.01% 3781
2020
Q1 		– Sell
-12,800
Closed -$1.4M – 5414
2019
Q4 		$1.4M Buy
+12,800
New +$1.24M ﹤0.01% 3902

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Goldman Sachs's MED Position: Q2 2026 in Review

Goldman Sachs increased its Medifast (MED) stake by 59% in Q2 2026, buying an estimated $1.04M and bringing the position to 243,085 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4468.

Goldman Sachs first reported a position in MED in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.1M in Q3 2018. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Goldman Sachs held 243,085 shares of Medifast worth $2.58M as of Q2 2026.
  • Goldman Sachs bought 89,914 Medifast shares in Q2 2026, an estimated $1.04M.
  • Medifast made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4468 holding.
  • Goldman Sachs first reported a position in Medifast in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Medifast position peaked at $56.1M in Q3 2018.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.